Clinical Trials
39
Active:0
Completed:10
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:17
Phase 2:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials
Phase 1
17 (60.7%)Not Applicable
5 (17.9%)Phase 2
4 (14.3%)Early Phase 1
1 (3.6%)Phase 3
1 (3.6%)Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC
Not yet recruiting
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: Atezolizumab+Bevacizumab+Carboplatin+Paclitaxel
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Fuzhou General Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT07093762
- Locations
- 🇨🇳
The 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou, Fujian, China, 350025, Fuzhou, China
SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer
Not yet recruiting
- Conditions
- Lung Cancer in Normal and Malignant Tumors
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-31
- Lead Sponsor
- Fuzhou General Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06772376
SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
Not yet recruiting
- Conditions
- Lung Cancers
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-31
- Lead Sponsor
- Fuzhou General Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06772363
- Locations
- 🇨🇳
Raman detector, Fuzhou, Fujian, China
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
Not yet recruiting
- Conditions
- Lung Cancer, Non-Small CellLung Cancer Small Cell Lung Cancer (SCLC)
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-31
- Lead Sponsor
- Fuzhou General Hospital
- Target Recruit Count
- 223
- Registration Number
- NCT06775002
SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer
Not yet recruiting
- Conditions
- Lung Cancer Patients
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-31
- Lead Sponsor
- Fuzhou General Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06775015
- Locations
- 🇨🇳
The 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou, Fujian, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
No news found